• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 231/14 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 231/14

Total number of patents in this class: 1155

10-year publication summary

92
63
84
69
62
64
72
57
46
28
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Bayer Cropscience AG
2040
64
Syngenta Participations AG
1904
50
Theravance Biopharma R&D IP, LLC
456
49
BASF SE
20940
35
Syngenta Crop Protection AG
6074
22
BioCryst Pharmaceuticals, Inc.
174
22
Takeda Pharmaceutical Company Limited
2708
19
Orion Corporation
670
19
Syngenta Limited
454
16
Sumitomo Chemical Company, Limited
9043
16
Activesite Pharmaceuticals, Inc.
19
16
KalVista Pharmaceuticals Limited
113
15
AstraZeneca AB
2892
12
Solvay SA
987
12
sanofi-aventis
363
12
F. Hoffmann-La Roche AG
7947
11
Dow AgroSciences LLC
1223
11
Rezolute, Inc.
32
11
Hoffmann-La Roche Inc.
3439
10
Bayer Intellectual Property GmbH
2498
10
Other owners 723